Ronald Feinberg

Dr. Ronald Feinberg is a board certified reproductive endocrinologist and physician scientist, who serves as Chief Medical Officer and Medical Director of IVF Programs at RADfertility. Dr. Feinberg has been caring for patients with reproductive and family building challenges for over 25 years and is one of the founding partners at RADfertility.

A proud Philadelphia native, Dr. Feinberg is a graduate of La Salle University, and achieved MD and PhD degrees from the University of Pennsylvania. His clinical training was at Yale-New Haven Hospital for OB/GYN residency, and at Penn for fellowship in reproductive endocrinology and infertility. While an assistant professor at Penn, Dr. Feinberg was awarded independent research grants from the March of Dimes and the NIH.

Under Dr. Feinberg’s guidance, RADfertility’s multi-year commitment to single embryo transfer and preimplantation genetic testing has achieved safer, healthier pregnancies and nationally-recognized success rates. His background and efforts in translational and clinical research have focused on the key “seeds and soil” issues of assisted reproduction that promote healthy embryo-endometrial implantation. As IVF Director of RADfertility, he led efforts toward 100% single embryo transfer in the practice, and has utilized RADfertility’s outcomes to advocate for fertility care legislative insurance mandates in Delaware.

Dr. Feinberg currently serves as adjunct faculty at the University of Delaware and the ChristianaCare Health System, and has been the Principal Investigator for numerous clinical trials. In addition, he has co-authored hundreds of journal articles, book chapters, and national presentations.

Dr. Ronald Feinberg has been named a 2023 Top Doctor by Delaware Today.